Release Date: 31/03/10 13:05 Summary: Response to ASX Price and Volume Query Price Sensitive: Yes Download Document 54.04KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%